Mankind Pharma IPO listing: Manforce condom maker off listing high, but remains well among India's top 100 most valuable firms
Mankind Pharma IPO listing: Mankind Pharma — whose popular brands include Manforce and Prega News — made a blockbuster debut on stock exchanges BSE and NSE on May 9, finishing the listing day at a premium of 32 per cent over the upper end of its IPO price range.
Even as the newly-listed Mankind Pharma shares took a breather on their second day on Dalal Street, the pharma and healthcare products company remained well among the country's top 100 most valuable companies. The stock of Mankind Pharma — whose popular products include Manforce condoms and Prega News pregnancy test kits — fell more than six per cent on Wednesday, but that did not force the company out of India's top 100 club in terms of market capitalisation (mcap) or market value. In fact, the company stays well among the top 90.
At the current market price, of Rs 1,424.1 per share, Mankind Pharma's market value stands at Rs 57,045.8 crore, according to provisional exchange data. To put things into perspective, Mankind Pharma has a market cap larger than 14 of the country's biggest 100 companies, and four pharma companies combined.
Here's a list of companies that lag the new kid on the block, Mankind Pharma, among the top 100:
| Company | CMP (in rupees per share) | Mcap (in crore rupees) |
| Bosch | 19,227.6 | 56,709 |
| Torrent Pharma | 1,649.4 | 55,819 |
| PNB | 50.3 | 55,374.4 |
| Canara Bank | 302.8 | 54,931.9 |
| ICICI Lombard General Insurance Company | 1,098.2 | 53,933.7 |
| Indian Hotels | 374.2 | 53,151.4 |
| Zydus Lifesciences | 524.7 | 53,110.4 |
| UPL | 694.6 | 53,070.6 |
| Tube Investments of India | 2,724.3 | 52,612 |
| PI Industries | 3,459.3 | 52,483.1 |
| Zomato | 60.9 | 52,281.6 |
| Hero MotoCorp | 2,591.8 | 51,793.5 |
| Samvardhana Motherson International | 75.9 | 51,445.6 |
| Trent | 1,432 | 50,904 |
ALSO READ: A stellar market debut for Manforce condom maker; shares finish listing day at 32% premium
Mankind Pharma's mcap even exceeds the total market cap of four pharma companies combined. These are: Granules India, Glenmark Pharma, Laurus Labs and Sanofi India.
| Company | CMP (in rupees) | Mcap (in crore rupees) |
| Granules India | 301.5 | 7,297.6 |
| Glenmark Pharma | 570.5 | 16,100.5 |
| Laurus | 332.3 | 17,883.2 |
| Sanofi | 5,670 | 13,042 |
| Total | 54,323.3 | |
The IPO of Mankind Pharma, the fourth largest drug maker in the country by domestic sales, is the first in the pharma space to have made money for investors since November 2021.
ALSO READ: Buy, sell or hold Mankind Pharma shares after stellar debut?
Mankind Pharma: A bumper listing following a long wait
The listing of Mankind Pharma is among the strongest over the recent years, and comparable with the IPOs and debuts of 2021 — a blockbuster year for the primary market that saw 66 mainstream initial share sales in total.
On May 9, Mankind Pharma debuted on stock exchanges BSE and NSE at a premium of 20 per cent over the issue price, and finished the listing day at a premium of 32 per cent.
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
03:33 PM IST
Ban on condom commercials ‘counterproductive’ for India, says Brand Guru